Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIVASTIGMINE vs ROCURONIUM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIVASTIGMINE vs ROCURONIUM: Safety Overview

Metric RIVASTIGMINE ROCURONIUM
Total FAERS Reports 9,123 6,477
Deaths Reported 2,232 424
Death Rate 24.5% 6.5%
Hospitalizations 2,716 1,982
Average Patient Age 80.0 yrs 50.3 yrs
% Female Patients 59.5% 52.6%
FDA Approval Date Apr 21, 2000 Apr 12, 2017
Manufacturer Novartis Pharmaceuticals Corporation HF Acquisition Co LLC, DBA HealthFirst
Route TRANSDERMAL INTRAVENOUS
Marketing Status Discontinued Discontinued